Home/Filings/4/0001127602-22-014973
4//SEC Filing

Keresty Georgia 4

Accession 0001127602-22-014973

CIK 0000929940other

Filed

May 17, 8:00 PM ET

Accepted

May 18, 4:45 PM ET

Size

15.8 KB

Accession

0001127602-22-014973

Insider Transaction Report

Form 4
Period: 2022-05-16
Transactions
  • Disposition to Issuer

    Common Stock

    2022-05-163,4650 total
  • Disposition to Issuer

    Director Stock Option (Right to Buy)

    2022-05-161,4440 total
    Exercise: $133.20Exp: 2029-09-02Common Stock (1,444 underlying)
  • Disposition to Issuer

    Director Stock Option (Right to Buy)

    2022-05-163030 total
    Exercise: $130.51Exp: 2030-12-27Common Stock (303 underlying)
  • Disposition to Issuer

    Director Stock Option (Right to Buy)

    2022-05-161,5310 total
    Exercise: $129.50Exp: 2031-08-31Common Stock (1,531 underlying)
  • Disposition to Issuer

    Director Stock Option (Right to Buy)

    2022-05-161,6840 total
    Exercise: $109.97Exp: 2029-04-16Common Stock (1,684 underlying)
Footnotes (8)
  • [F1]On May 16, 2022, the closing of the transactions contemplated by the Transaction Agreement and Plan of Merger, dated as of October 10, 2021, as amended, among Aspen Technology, Inc. ("AspenTech"), Emerson Electric Co., Emersub CX, Inc., ("New AspenTech") and certain other parties, occurred, pursuant to which AspenTech merged with a wholly owned subsidiary of New AspenTech (the "Merger"). Pursuant to the Merger, AspenTech became a wholly owned subsidiary of New AspenTech.
  • [F2]At the effective time of the Merger (the "Effective Time"), each outstanding share of the AspenTech common stock (other than certain excluded shares) automatically converted into the right to receive $87.69 in cash (the "Cash Consideration"), plus 0.42 of a validly issued, fully paid and nonassessable share of New AspenTech.
  • [F3]One third of the option granted at the exercise price of $109.97 will vest on the first anniversary of the grant date and the remainder will vest in eight equal consecutive quarterly installments on the last business day of the quarter until fully vested.
  • [F4]Each converted equity award described herein shall be subject to the same terms and conditions (including vesting and expiration schedule, as applicable) as applied to the corresponding AspenTech equity award as of immediately prior to the Effective Time.
  • [F5]Each AspenTech stock option ("AspenTech Stock Option") outstanding immediately prior to the Effective Time was cancelled and assumed by New AspenTech and converted into the right to receive a New AspenTech stock option ("Converted Option") covering that number of shares of New AspenTech common stock, rounded down to the nearest whole share, equal to the product of (i) the number of shares of AspenTech common stock underlying the corresponding AspenTech Stock Option as of immediately prior to the Effective Time multiplied by (ii) the Aspen Equity Award Exchange Ratio. The exercise price applicable to each Converted Option shall be equal to (i) the exercise price per share of AspenTech common stock applicable to the corresponding AspenTech Stock Option as of immediately prior to the Effective Time divided by (ii) the Aspen Equity Award Exchange Ratio, rounded up to the nearest whole cent.
  • [F6]The option granted at the exercise price of $133.20 was fully vested on the date of grant.
  • [F7]The option granted at the exercise price of $130.51 was fully vested on the date of grant.
  • [F8]The option granted at the exercise price of $129.50 was fully vested on the date of grant.

Issuer

ASPENTECH Corp

CIK 0000929940

Entity typeother

Related Parties

1
  • filerCIK 0001773532

Filing Metadata

Form type
4
Filed
May 17, 8:00 PM ET
Accepted
May 18, 4:45 PM ET
Size
15.8 KB